DR is a pathology initiated by hyperglycemia which overall (i) increases polyol pathway flux; (ii) increases advanced glycation end-product (AGE) formation; (iii) activates protein kinase C (PKC) isoforms; and (iv) increases hexosamine pathway flux [40]. This evidence concerns the gene PRRT2 and Hyperglycemia.